Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Biotechnol Bioeng ; 120(3): 674-686, 2023 03.
Article in English | MEDLINE | ID: mdl-36514261

ABSTRACT

Thermobifida fusca cutinase (TfCut2) is a carboxylesterase (CE) which degrades polyethylene terephthalate (PET) as well as its degradation intermediates [such as oligoethylene terephthalate (OET), or bis-/mono-hydroxyethyl terephthalate (BHET/MHET)] into terephthalic acid (TPA). Comparisons of the surfaces of certain CEs (including TfCut2) were combined with docking and molecular dynamics simulations involving 2HE-(MHET)3, a three-terephthalate OET, to support the rational design of 22 variants with potential for improved generation of TPA from PET, comprising 15 single mutants (D12L, E47F, G62A, L90A, L90F, H129W, W155F, ΔV164, A173C, H184A, H184S, F209S, F209I, F249A, and F249R), 6 double mutants [H129W/T136S, A173C/A206C, A173C/A210C, G62A/L90F, G62A/F209I, and G62A/F249R], and 1 triple mutant [G62A/F209I/F249R]. Of these, nine displayed no activity, three displayed decreased activity, three displayed comparable activity, and seven displayed increased (~1.3- to ~7.2-fold) activity against solid PET, while all variants displayed activity against BHET. Of the variants that displayed increased activity against PET, four displayed more activity than G62A, the most-active mutant of TfCut2 known till date. Of these four, three displayed even more activity than LCC (G62A/F209I, G62A/F249R, and G62A/F209I/F249R), a CE known to be ~5-fold more active than wild-type TfCut2. These improvements derived from changes in PET binding and not changes in catalytic efficiency.


Subject(s)
Hydrolases , Polyethylene Terephthalates , Polyethylene Terephthalates/metabolism , Hydrolases/chemistry , Hydrolysis , Carboxylic Ester Hydrolases/genetics , Carboxylic Ester Hydrolases/metabolism , Mutagenesis
2.
Genetics ; 221(4)2022 07 30.
Article in English | MEDLINE | ID: mdl-35666203

ABSTRACT

Cytochrome c oxidase (CcO) is a multimeric copper-containing enzyme of the mitochondrial respiratory chain that powers cellular energy production. The two core subunits of cytochrome c oxidase, Cox1 and Cox2, harbor the catalytic CuB and CuA sites, respectively. Biogenesis of each copper site occurs separately and requires multiple proteins that constitute the mitochondrial copper delivery pathway. Currently, the identity of all the members of the pathway is not known, though several evolutionarily conserved twin CX9C motif-containing proteins have been implicated in this process. Here, we performed a targeted yeast suppressor screen that placed Coa4, a twin CX9C motif-containing protein, in the copper delivery pathway to the Cox1 subunit. Specifically, we show that overexpression of Cox11, a copper metallochaperone required for the formation of CuB site, can restore Cox1 abundance, cytochrome c oxidase assembly, and mitochondrial respiration in coa4Δ cells. This rescue is dependent on the copper-coordinating cysteines of Cox11. The abundance of Coa4 and Cox11 in mitochondria is reciprocally regulated, further linking Coa4 to the CuB site biogenesis. Additionally, we find that coa4Δ cells have reduced levels of copper and exogenous copper supplementation can partially ameliorate its respiratory-deficient phenotype, a finding that connects Coa4 to cellular copper homeostasis. Finally, we demonstrate that human COA4 can replace the function of yeast Coa4 indicating its evolutionarily conserved role. Our work provides genetic evidences for the role of Coa4 in the copper delivery pathway to the CuB site of cytochrome c oxidase.


Subject(s)
Electron Transport Complex IV , Saccharomyces cerevisiae , Copper , Electron Transport Complex IV/genetics , Electron Transport Complex IV/metabolism , Humans , Mitochondria/genetics , Mitochondria/metabolism , Mitochondrial Proteins/genetics , Mitochondrial Proteins/metabolism , Saccharomyces cerevisiae/metabolism
3.
Stem Cell Reports ; 14(5): 745-754, 2020 05 12.
Article in English | MEDLINE | ID: mdl-32359444

ABSTRACT

Recently, a unique form of X chromosome dosage compensation has been demonstrated in human preimplantation embryos, which happens through the dampening of X-linked gene expression from both X chromosomes. Subsequently, X chromosome dampening has also been demonstrated in female human pluripotent stem cells (hPSCs) during the transition from primed to naive state. However, the existence of dampened X chromosomes in both embryos and hPSCs remains controversial. Specifically, in preimplantation embryos it has been shown that there is inactivation of X chromosome instead of dampening. Here, we performed allelic analysis of X-linked genes at the single-cell level in hPSCs and found that there is partial reactivation of the inactive X chromosome instead of chromosome-wide dampening upon conversion from primed to naive state. In addition, our analysis suggests that the reduced X-linked gene expression in naive hPSCs might be the consequence of erasure of active X chromosome upregulation.


Subject(s)
Human Embryonic Stem Cells/metabolism , X Chromosome Inactivation , Alleles , Female , Humans , RNA, Long Noncoding/genetics , Single-Cell Analysis
4.
Chromosoma ; 129(2): 111-113, 2020 06.
Article in English | MEDLINE | ID: mdl-31273451

ABSTRACT

The recent report of X-chromosome dampening in human preimplantation embryos remains controversial. Subsequently, Sahakyan et al. found evidence of X-chromosome dampening in human naïve pluripotent stem cells (hPSCs) as well. Here, we discuss whether X-dampening reported in hPSCs truly reflects the dampening of X-chromosomes or it is a consequence of the erasure of X-chromosome upregulation.


Subject(s)
Chromosomes, Human, X , Dosage Compensation, Genetic , Gene Dosage , Gene Expression Regulation , Pluripotent Stem Cells/metabolism , Animals , Embryonic Development/genetics , Humans , Pluripotent Stem Cells/cytology , Up-Regulation
5.
Int J Biol Macromol ; 145: 950-964, 2020 Feb 15.
Article in English | MEDLINE | ID: mdl-31669274

ABSTRACT

To overcome the practical limitations of hydrogel preparations, applications and strength-based problems, the present study utilizes the use of sprayers for preparing polyvinyl alcohol/chitosan (PVA/CH) hydrogels. The particle size, morphology, stability, release studies and antibacterial activity of silver nanoparticles (AgNPs) had been studied. The particle size of AgNPs was found to be in the range of 4.59-10 nm (75 °C) with a polydispersity index (PDI) of 0.84. The morphological images exhibited inter-connecting porous structure with pore size in submicron's (<1 µm). Major infra-red spectral peaks of PVA (2946.67 cm-1; stretching of CH, 1142.72 cm-1; CO stretching) and CH (3287.49 cm-1; OH stretching, 2917.48 cm-1; CH stretching) maintain their place in PVA/CH and PVA/CH/Ag hydrogels. In addition, X-ray diffraction (XRD) pattern showed peaks with 2θ values at 38.08°, 44.29° and 64.50° corresponding to the crystal planes of (1 1 1), (2 0 0) and (2 2 0), respectively, allocated to face-centered cubic crystalline structure of AgNPs. The drug release and antibacterial studies showed a maximum release of 91.83% from hydrogels and a concentration dependent zone of inhibition (ZOI) for >24 h, respectively. Thus, the newly developed sprayed hydrogels could turn out to be a suitable dressing material for wound healing applications.


Subject(s)
Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Chitosan/chemistry , Metal Nanoparticles/chemistry , Nanogels/chemistry , Polyvinyl Alcohol/chemistry , Silver/chemistry , Bandages , Chitosan/pharmacology , Drug Liberation , Eucalyptus , Green Chemistry Technology , Hydrogels/chemistry , Kinetics , Methylgalactosides/chemistry , Microbial Sensitivity Tests , Particle Size , Polyvinyl Alcohol/pharmacology , Rheology , Silver/pharmacology , Wound Healing/drug effects , X-Ray Diffraction
6.
Article in English | MEDLINE | ID: mdl-30785097

ABSTRACT

In E. coli, a single oligomeric enzyme transcribes the genomic DNA, while multiple auxiliary proteins and regulatory RNA interact with the core RNA polymerase (RP) during different stages of the transcription cycle to influence its function. In this work, using fast protein isolation techniques combined with mass spectrometry (MS) and immuno-analyses, we studied growth phase-specific changes in the composition of E. coli transcription complexes. We show that RP isolated from actively growing cells is represented by prevalent double copy assemblies and single copy RP-RNA and RP-RNA-RapA complexes. We demonstrate that RpoD/σ70 obtained in fast purification protocols carries tightly associated RNA and show evidence pointing to a role of sigma-associated RNA in the formation of native RP-(RNA)-RpoD/σ70 (holoenzyme) complexes. We report that enzymes linked functionally to the metabolism of lipopolysaccharides co-purify with RP-RNA complexes and describe two classes of RP-associated molecules (phospholipids and putative phospholipid-rNT species). We hypothesize that these modifications could enable anchoring of RP-RNA and RNA in cell membranes. We also report that proteins loosely associated with ribosomes and degradosomes (S1, Hfq) co-purify with RP-RNA complexes isolated from actively growing cells - a result consistent with their proposed roles as adaptor-proteins. In contrast, GroEL, SecB, and SecA co-purified with RP obtained from cells harvested in early stationary phase. Our results demonstrate that fast, affinity chromatography-based isolation of large multi-protein assemblies in combination with MS can be used as a tool for analysis of their composition and the profiling of small protein-associated molecules (SPAM).


Subject(s)
DNA-Directed RNA Polymerases/metabolism , Escherichia coli Proteins/metabolism , Escherichia coli , RNA, Bacterial/metabolism , Chromatography, High Pressure Liquid , DNA-Directed RNA Polymerases/chemistry , DNA-Directed RNA Polymerases/isolation & purification , Electrophoresis, Polyacrylamide Gel , Escherichia coli/chemistry , Escherichia coli/genetics , Escherichia coli/metabolism , Escherichia coli Proteins/chemistry , Escherichia coli Proteins/isolation & purification , Macromolecular Substances/chemistry , Macromolecular Substances/isolation & purification , Macromolecular Substances/metabolism , RNA, Bacterial/chemistry , RNA, Bacterial/isolation & purification , Transcription, Genetic
7.
Lipids Health Dis ; 8: 55, 2009 Dec 16.
Article in English | MEDLINE | ID: mdl-20015371

ABSTRACT

BACKGROUND: Atherosclerosis is a chronic disorder of the arterial wall that starts by formation of fatty streaks and gradually evolves into atherosclerotic plaques. High-density lipoproteins (HDL) blood levels are inversely correlated with atherosclerosis. This beneficial effect of HDL has been partly attributed to its antioxidant properties mediated by paraoxonase1 (PON1) or platelet-activating factor acetylhydrolase (PAF-AH). The present study was aimed to study HDL associated enzymes i.e. PON1 and PAF-AH under experimental hypercholesterolemia and their possible modulation on selenium (Se; an antioxidant) supplementation. Male Sprague Dawley rats were divided into three groups and fed on the control diet, high fat diet (HFD) and HFD + Se respectively for the period of 4 months. RESULTS: Cholesterol, triglycerides, HDL and LDL levels were significantly increased by HFD feeding. Selenium supplementation lowered the triglyceride level, whereas the other lipid values remained unchanged. Serum selenium levels were reduced by 31% and ROS levels in the liver were 2-fold increased by HFD. Se supplementation, however, diminished the HFD-induced ROS levels by 29%. Furthermore, Se also improved the HFD-mediated reduction of serum PON1 enzyme activity by 34% and PON1 protein levels by 21%. However, no significant effect of Se was detected on the reduced PAF-AH proteins levels in HFD fed rats. mRNA expression of PON1 and PAF-AH in the liver was not affected in the Se treated groups. CONCLUSION: Se supplementation appears to be protective in hypercholesterolemia by restoring the antioxidant properties of the HDL associated enzyme i.e. PON1 whereas biological system aims towards maintaining the same PAF-AH levels even on selenium supplementation indicating its probable role in both anti and pro-atherogenic activities. Therefore, Se supplementation might be a valuable approach to limit the adverse effects of hypercholesterolemia and may need further investigations.


Subject(s)
Dietary Supplements , Hypercholesterolemia/drug therapy , Hypercholesterolemia/enzymology , Lipoproteins, HDL/blood , Selenium/therapeutic use , 1-Alkyl-2-acetylglycerophosphocholine Esterase/genetics , 1-Alkyl-2-acetylglycerophosphocholine Esterase/metabolism , Animals , Aryldialkylphosphatase/genetics , Aryldialkylphosphatase/metabolism , Enzyme-Linked Immunosorbent Assay , Gene Expression Regulation, Enzymologic/drug effects , Hypercholesterolemia/blood , Male , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Selenium/administration & dosage , Selenium/blood , Selenium/pharmacology
8.
Clin Cancer Res ; 14(5): 1561-70, 2008 Mar 01.
Article in English | MEDLINE | ID: mdl-18316581

ABSTRACT

Acquirement of resistance to rituximab has been observed in lymphoma patients. To define mechanisms associated with rituximab resistance, we developed various rituximab-resistant cell lines (RRCL) and studied changes in CD20 expression/structure, lipid raft domain (LRD) reorganization, calcium mobilization, antibody-dependent cellular cytotoxicity, and complement-mediated cytotoxicity (CMC) between parental and RRCL. Significant changes in surface CD20 antigen expression were shown in RRCL. Decreased calcium mobilization and redistribution of CD20 into LRD were found in RRCL. Western blotting identified a unique 35 kDa protein band in RRCL, which was not seen in parental cells and was secondary to an increase in surface and cytoplasmic expression of IgM light chains. CD20 gene expression was decreased in RRCL. In vitro exposure to PS341 increased CD20 expression in RRCL and minimally improved the sensitivity to rituximab-associated CMC. Our data strongly suggest that the acquisition of rituximab resistance is associated with global gene and protein down-regulation of the CD20 antigen affecting LRD organization and downstream signaling. CD20 expression seems to be regulated at the pretranscriptional and posttranscriptional levels. Proteasome inhibition partially reversed rituximab resistance, suggesting the existence of additional mediators of rituximab resistance. Future research is geared to identify drugs and/or biological agents that are effective against RRCL.


Subject(s)
Antibodies, Monoclonal/pharmacology , Antigens, CD20/genetics , Antigens, CD20/metabolism , Antineoplastic Agents/pharmacology , Drug Resistance, Neoplasm , Lymphoma, B-Cell/drug therapy , Transcription, Genetic/drug effects , Antibodies, Monoclonal, Murine-Derived , Antibody-Dependent Cell Cytotoxicity , Apoptosis/drug effects , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , Blotting, Northern , Blotting, Western , Boronic Acids/pharmacology , Bortezomib , Calcium/metabolism , Down-Regulation , Flow Cytometry , Gene Expression Profiling , Humans , Immunoglobulins/metabolism , Lymphoma, B-Cell/immunology , Lymphoma, B-Cell/metabolism , Membrane Microdomains/drug effects , Oligonucleotide Array Sequence Analysis , Phenotype , Protease Inhibitors/pharmacology , Proteasome Inhibitors , Pyrazines/pharmacology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Rituximab , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...